跳至主要内容
临床试验/NCT01763619
NCT01763619Unknown不适用

Freedom® Cervical Disc Use In The Treatment of Cervical Degenerative Disc Disease

AxioMed Spine Corporation5 个研究点 分布在 2 个国家目标入组 50 人开始时间: 2013年2月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
入组人数
50
试验地点
5
主要终点
Safety of FCD

研究概览

简要总结

This study will collect clinical and radiographic data on the Freedom Cervical Disc to monitor the device's safety and performance as part of a post-market evaluation.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Skeletally mature males or females, aged 21 to 65 years old, inclusive.
  • •Single, or adjacent, 2-level degenerative disc disease at C3-C7, inclusive.
  • •Subject is a surgical candidate for an anterior approach to the cervical spine.
  • •Minimum of 6 weeks of unsuccessful conservative treatment.
  • •Subject with at least moderate preoperative pain and functional impairment
  • •Subject is mentally and physically able to comply with protocol, postoperative compliance instructions, and follow-up schedule through 2-years.
  • •Subject must understand and sign the written Informed Consent form.

排除标准

  • •Subject with axial neck pain only who does not demonstrate concurrent arm pain or progressive neurological deterioration (specifically numbness or muscle weakness in the arm).
  • •An active infection at the operative site or active systemic infection at the time of surgery.
  • •Known or suspected allergy to titanium, polyurethane, cobalt, chromium, molybdenum or silicone.
  • •Previous spinal fusion at the involved, or adjacent, cervical level(s).
  • •Congenital or acquired structural defect at the operative levels (s) or their immediately adjacent level(s).
  • •Significant osteoporosis in the cervical spine.
  • •The investigator should assess if the subject has any of the following conditions at the index or adjacent level(s) which excludes the subject from study participation:
  • •Cervical facet degeneration of the involved C3-C7 levels.
  • •Previous trauma to, or fusion in, the C3-C7 levels.
  • •Cervical instability at the index level(s) on neutral lateral or flexion/extension x-rays.
  • •Radiographic findings of a fused or total collapsed disc.
  • •Significant global cervical kyphosis (≥15º on Cobb angle measurement) or significant reversal of lordosis.
  • •Female of childbearing potential, pregnant, breast feeding, or interested in becoming pregnant in the next two years

研究组 & 干预措施

Freedom Cervical Disc

Experimental

干预措施: Freedom Cervical Disc (Device)

结局指标

主要结局

Safety of FCD

时间窗: 6 months

Monitor the safety (operative and post-operative adverse events through 6-months) of the FCD.

Performance of FCD

时间窗: 6 months

Monitor the performance (radiographic evaluation of segmental non-fusion and device function) of the FCD through 6-months post-operative period.

次要结局

  • Incidence of AEs(2 year)
  • Neck/Arm Pain(2 years)
  • Neurological function(2 years)
  • Subject Function(2 years)
  • Radiographic Measurements(2 years)
  • Examine AEs(2 years)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验